CR11270A - Pirimidinas biciclicas fusionadas - Google Patents

Pirimidinas biciclicas fusionadas

Info

Publication number
CR11270A
CR11270A CR11270A CR11270A CR11270A CR 11270 A CR11270 A CR 11270A CR 11270 A CR11270 A CR 11270A CR 11270 A CR11270 A CR 11270A CR 11270 A CR11270 A CR 11270A
Authority
CR
Costa Rica
Prior art keywords
fusioned
pyrimidins
bicycle
tautomers
stereoisomers
Prior art date
Application number
CR11270A
Other languages
English (en)
Inventor
Swen Holder
Matthias Vennemann
Gerrit Beneke
Armin Zulch
Volker Gekeler
Thomas Beckers
Astrid Zimmermann
Hemant Joshi
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07118736A external-priority patent/EP2050748A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR11270A publication Critical patent/CR11270A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Compuestos de formula (I) los tautomeros o los estereoisomeros de estos o las sales de estos, donde el anillo B y la pirimidina a la que esta fusionado.
CR11270A 2007-08-14 2010-02-12 Pirimidinas biciclicas fusionadas CR11270A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1572MU2007 2007-08-14
EP07118736A EP2050748A1 (en) 2007-10-18 2007-10-18 Novel fused pyrimidines

Publications (1)

Publication Number Publication Date
CR11270A true CR11270A (es) 2010-05-19

Family

ID=40153211

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11270A CR11270A (es) 2007-08-14 2010-02-12 Pirimidinas biciclicas fusionadas

Country Status (37)

Country Link
US (2) US7776864B2 (es)
EP (1) EP2188291B1 (es)
JP (1) JP5344637B2 (es)
KR (1) KR20100053556A (es)
CN (1) CN101778851B (es)
AR (1) AR067945A1 (es)
AU (1) AU2008288392B2 (es)
BR (1) BRPI0815207A2 (es)
CA (1) CA2694058C (es)
CL (1) CL2008002398A1 (es)
CO (1) CO6260077A2 (es)
CR (1) CR11270A (es)
CY (1) CY1113486T1 (es)
DK (1) DK2188291T3 (es)
DO (1) DOP2010000058A (es)
EA (1) EA020996B1 (es)
EC (1) ECSP109964A (es)
ES (1) ES2396177T3 (es)
HN (1) HN2010000313A (es)
HR (1) HRP20121022T1 (es)
IL (1) IL203163A (es)
MA (1) MA31608B1 (es)
MX (1) MX2010001746A (es)
MY (1) MY169738A (es)
NZ (1) NZ583267A (es)
PA (1) PA8793201A1 (es)
PE (1) PE20090944A1 (es)
PL (1) PL2188291T3 (es)
PT (1) PT2188291E (es)
RS (1) RS52559B (es)
SI (1) SI2188291T1 (es)
SV (1) SV2010003483A (es)
TN (1) TN2010000070A1 (es)
TW (1) TWI439272B (es)
UA (1) UA99735C2 (es)
UY (1) UY31293A1 (es)
WO (1) WO2009021992A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410087B2 (en) * 2006-10-19 2013-04-02 Takeda Pharmaceutical Company Limited Indole compound
CL2008002398A1 (es) 2007-08-14 2009-07-31 Bayer Ip Gmbh Compuestos derivados de 6-(fenil piperidina) pirimidinas fusionadas con imidazol, triazol o pirozol, inhibidores de la via pi3k/akt; composicion farmaceutica; combinacion farmaceutica; y uso de los compuestos para el tratamiento de la neoplasia benigna y/o maligna y para el cancer.
EP2307400B1 (en) 2008-05-30 2014-04-23 Amgen, Inc Inhibitors of pi3 kinase
JP5667085B2 (ja) * 2009-02-13 2015-02-12 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ Ａｋｔインヒビターとしての融合されたピリミジン
AU2010213192A1 (en) * 2009-02-13 2011-08-04 Bayer Intellectual Property Gmbh Fused pyrimidines
US8691825B2 (en) 2009-04-01 2014-04-08 Merck Sharp & Dohme Corp. Inhibitors of AKT activity
JPWO2010125799A1 (ja) 2009-04-27 2012-10-25 塩野義製薬株式会社 Ｐｉ３ｋ阻害活性を有するウレア誘導体
CN103189379A (zh) * 2010-07-13 2013-07-03 拜耳知识产权有限责任公司 双环嘧啶
CA2806655A1 (en) 2010-07-28 2012-02-02 Bayer Intellectual Property Gmbh Substituted imidazo[1,2-b]pyridazines
DK2694510T3 (en) 2011-04-07 2016-01-18 Bayer Ip Gmbh IMIDAZOPYRIDAZINER AS AKT kinase inhibitors
MA38287B1 (fr) 2013-01-23 2018-08-31 Astrazeneca Ab Nouveaux dérivés aminopyrazine pour le traitement ou la prévention du cancer
US20140274685A1 (en) 2013-03-15 2014-09-18 Bayer Cropscience Lp Compositions, additives, and methods for mitigating or controlling seed dust
EP2967030A2 (en) * 2013-03-15 2016-01-20 Bayer CropScience LP Compositions, additives, and methods for mitigating or controlling seed dust
MX2020002869A (es) 2017-09-15 2020-07-24 Aduro Biotech Inc Compuestos de pirazolopirimidinona y usos de los mismos.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2413802A1 (en) 2000-06-30 2002-01-10 Mark R. Schmitt Substituted-triazolopyrimidines as anticancer agents
US7449488B2 (en) * 2002-06-04 2008-11-11 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
AU2004233828B2 (en) 2003-04-24 2009-05-28 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
DE602005026509D1 (de) 2004-04-09 2011-04-07 Merck Sharp & Dohme Hemmer der akt aktivität
TW200618800A (en) * 2004-08-03 2006-06-16 Uriach Y Compania S A J Heterocyclic compounds
EP1784175A4 (en) * 2004-08-23 2009-07-22 Merck & Co Inc INHIBITORS OF ACT ACTIVITY
AU2005316826A1 (en) 2004-12-15 2006-06-22 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
JP5274842B2 (ja) * 2004-12-28 2013-08-28 エグゼリクシス， インコーポレイテッド 免疫疾患、炎症疾患および増殖疾患の処置のためのセリン−スレオニンキナーゼモジュレーター（ｐ７０Ｓ６Ｋ、Ａｋｔ−１およびＡｋｔ−２）としての［１Ｈ−ピペラゾ［３，４−ｄ］ピリミジン−４−イル］−ピペラジンまたは［１Ｈ−ピペラゾ［３，４−ｄ］ピリミジン−４−イル］−ピペラジン化合物
EP1850843A4 (en) 2005-02-14 2012-02-15 Merck Sharp & Dohme INHIBITORS OF ACT ACTIVITY
DK1898903T3 (da) 2005-06-10 2013-07-01 Merck Sharp & Dohme Inhibitorer af Akt-aktivitet
CL2008002398A1 (es) 2007-08-14 2009-07-31 Bayer Ip Gmbh Compuestos derivados de 6-(fenil piperidina) pirimidinas fusionadas con imidazol, triazol o pirozol, inhibidores de la via pi3k/akt; composicion farmaceutica; combinacion farmaceutica; y uso de los compuestos para el tratamiento de la neoplasia benigna y/o maligna y para el cancer.
AU2010213192A1 (en) * 2009-02-13 2011-08-04 Bayer Intellectual Property Gmbh Fused pyrimidines

Also Published As

Publication number Publication date
KR20100053556A (ko) 2010-05-20
CA2694058A1 (en) 2009-02-19
EP2188291A2 (en) 2010-05-26
CO6260077A2 (es) 2011-03-22
JP5344637B2 (ja) 2013-11-20
IL203163A (en) 2015-01-29
JP2010535848A (ja) 2010-11-25
TWI439272B (zh) 2014-06-01
HK1146273A1 (en) 2011-05-20
CL2008002398A1 (es) 2009-07-31
ECSP109964A (es) 2010-03-31
ES2396177T3 (es) 2013-02-19
RS52559B (sr) 2013-04-30
HRP20121022T1 (hr) 2013-01-31
UA99735C2 (uk) 2012-09-25
DK2188291T3 (da) 2013-01-07
US8614218B2 (en) 2013-12-24
PT2188291E (pt) 2012-12-20
CN101778851B (zh) 2013-05-08
MA31608B1 (fr) 2010-08-02
WO2009021992A3 (en) 2009-04-16
US7776864B2 (en) 2010-08-17
WO2009021992A2 (en) 2009-02-19
MX2010001746A (es) 2010-03-10
PL2188291T3 (pl) 2013-06-28
SV2010003483A (es) 2010-07-06
PE20090944A1 (es) 2009-08-09
EA020996B1 (ru) 2015-03-31
CA2694058C (en) 2016-06-07
AR067945A1 (es) 2009-10-28
EP2188291B1 (en) 2012-09-19
DOP2010000058A (es) 2010-02-28
US20100184782A1 (en) 2010-07-22
SI2188291T1 (sl) 2013-01-31
BRPI0815207A2 (pt) 2017-03-28
CN101778851A (zh) 2010-07-14
MY169738A (en) 2019-05-14
AU2008288392A1 (en) 2009-02-19
TW200922592A (en) 2009-06-01
AU2008288392B2 (en) 2013-10-24
CY1113486T1 (el) 2016-06-22
NZ583267A (en) 2012-03-30
HN2010000313A (es) 2013-03-18
US20090137607A1 (en) 2009-05-28
PA8793201A1 (es) 2009-04-23
UY31293A1 (es) 2009-03-31
TN2010000070A1 (en) 2011-09-26
EA201000298A1 (ru) 2010-10-29

Similar Documents

Publication Publication Date Title
CR11270A (es) Pirimidinas biciclicas fusionadas
CR10662A (es) Compuestos de metilpiridopirimidinona
CY1112102T1 (el) Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1
CR11271A (es) Imidazoles fusionados para el tratamiento del cancer
CO6321272A2 (es) Fosfatos ciclicos de nucleosidos.
CL2012002526A1 (es) Uso de compuestos inhibidores de dpp iv de formula (i) o (ii) o una de sus sales, para el tratamiento de falla cardiaca.
NO20090313L (no) Derivater og analoger av N-etylkinoloner og N-etylazakinoloner
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
CL2017003032A1 (es) Derivado de pirido[3,4-d]pirimidina y sal farmacéuticamente aceptable de éste
NI201000059A (es) Inhibidores de la cinasa c-fms.
CO6491082A2 (es) Derivados de n 1-sulfonil-5-fluoropirimidinona
SV2011003809A (es) Derivados de heteroarilo como inhibidores de dgat1
DOP2011000174A (es) Compuestos organicos
CR11241A (es) Compuestos de pirazol y su uso como inhibidores de raf
GT200800242A (es) Derivados biciclicos como inhibidores de cetp
NI200900155A (es) COMPUESTOS DE 2-AMINO PIRIMIDINA. Caso: PC 33441A
EA201100994A1 (ru) Способ получения производных бисфуранового спирта, соединения, соль, фармацевтическая композиция на ее основе, способ лечения или профилактики ретровирусных инфекций с ее помощью
ECSP12011652A (es) Derivados de 5-fluoro-2-oxopirimidinona-1 (2h)-carboxamida substituida-n1
CR11463A (es) Compuestos de piridilmetil-sulfonamida
MX2018013133A (es) Compuesto de pirazolo[1,5-a]pirimidina.
ME00582A (en) Tricyclic compound and pharmaceutical use thereof
UY30788A1 (es) Compuestos quimicos
UY31704A (es) Compuesto heterociclico fusionado
ECSP11011167A (es) Síntesis y formas de sales novedosas de (r) -5- ( (e) -2- (pirrolidin-3-ilvinil) pirimidina
UY29070A1 (es) Enantiómeros de heterocíclicos fusionados y sus usos